TrialMedicine2018

One-year outcomes of fixed treatment of intravitreal aflibercept for exudative age-related macular degeneration and the factor of visual prognosis.

Aoi Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.